Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case–control study, Spain, 2023/24 seasonOlivier Núñez, Carmen Olmedo, David Moreno‐Pérez et al.|Eurosurveillance|2025Cited by 25